Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Weight management in adults (Orlistat - Weight management in adults)

Records returned : 6 (on 04 Sep 2025 at 05:32:46). Return to search results for ' Weight management in adults '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Status :
Green
Formulations :
  • Capsules
Restrictions / Comments:

 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important

Access in PRIMARY Care via a Locally Commissioned Service (which includes wrap around support) ONLY

BMI ≥ 40 kg/m2 (BMI should be adjusted by -2.5 kg/m² for individuals from ethnic backgrounds, AND at least FOUR of the five following comorbidities:

  • Type 2 diabetes (T2DM), Hypertension, Dyslipidaemia, Cardiovascular disease (CVD), Obstructive sleep apnoea (OSA)

 

 
Links :
Status :
Blue
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important

Access through the specialist weight management service at Ashford & St Peters NHS Foundation Trust ONLY for patients in phase 1 here https://www.endocrinology.org/media/sjdpporx/joint-position-statement-on-medical-therapies-for-obesity_final-resubmitted-sfe-211223.pdf

After referral SWMS will consider appropriate initiation in line with cohort 1 here PRN01879-interim-commissioning-guidance-implementation-of-the-nice-technology-appraisal-ta1026-and-the-NICE-fu.pdf and will prescribe for 12 months prior to transfer of care.

 
Links :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Pre-filled pen
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
NICE
R
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NFD1
NICE
SPC